18F-GP1 is highly specific in recognising a culprit lesion from a non-culprit lesion both visually as well as quantitatively. FUNDING ACKNOWLEDGEMENT. Type of funding sources: Foundation. Main funding source(s): British Heart Foundation Figure 1Figure 2...
关联企业1 担任法定代表人1 担任股东0 担任高管0 所有任职企业1 作为最终受益人1 所属集团0 历史信息 曾担任法定代表人 曾担任股东 曾担任高管 所有曾任职企业 曾为最终受益人0 历史控股企业0 投资信息 控股企业0 间接持股企业0 爱企查图谱 任职全景图 股权穿透图 商业关系图 风险关注 司法案件0 失信被...
Muller, AndreZerna, MarionFriebe, MatthiasHutter, JoachimSociety of Nuclear Medicine Annual Meeting AbstractsStephens A, Lohrke J, Siebeneicher H, Berge M, Bauser M, Berndt M, et al. [18F]GP1, a novel fluorine-18 labeled tracer for PET imaging of thrombi. Eur J Nucl Med Mol Imaging. ...
Background 18F-GP1 is a novel positron emission tomography (PET) tracer that targets glycoprotein IIb/IIIa receptors on activated platelets. The study objective was to explore the feasibility of...doi:10.1186/s13550-018-0471-8Sun Young Chae...
F-GP1 is a novel highly specific radiotracer that binds to activated platelets and thrombus. We aimed to establish the observer repeatability of coronary, carotid and cerebralF-GP1 uptake in patients presenting with acute myocardial infarction or ischaemic stroke. Forty-three patients presenting with ...
F]GP1 activity was cleared by hepatobiliary and urinary excretion. The organ receiving the highest radiation absorbed dose (mGy/MBq) was the urinary bladder (0.0884±0.0458), followed by upper large intestine (0.0498±0.0189), small intestine (0.0454±0.0166), and kidneys (0.0350±0.0231). The ...
18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi"]]>Efficacy of FDG PET/CT imaging for venous thromboembolic disorders: preliminary results from a prospective, observational pilot study. Clin Nucl Med. 2015;40:e23–e26. 10. Rondina MT, Lam UT, ...
Arterial thrombosisPositron emission tomography18F-GP1Platelet activationGlycoprotein IIb/IIIa receptorBackground ~(18)F-GP1 is a novel positron emission tomography (PET) tracer that targets glycoprotein IIb/IIIa receptors on activated platelets. The study objective was to explore the feasibility of ...